Region: Global
Category: Medical Devices

Global Medical Devices

(14,024 reports matching your criteria)
  • Contact Lens Solutions

    ... at a CAGR of 3.7% over the analysis period 2024-2030. Multi Purpose, one of the segments analyzed in the report, is expected to record a 3.4% CAGR and reach US$2.5 Billion by the end of ... Read More

  • Surgical Incision Closures

    ... at a CAGR of 6.1% over the analysis period 2024-2030. Tissue Sealants, Adhesives & Topical Hemostats, one of the segments analyzed in the report, is expected to record a 7.2% CAGR and reach US$14.8 Billion ... Read More

  • Bone Densitometers

    ... CAGR of 5.6% over the analysis period 2024-2030. Axial Bone Densitometers, one of the segments analyzed in the report, is expected to record a 6.6% CAGR and reach US$264.5 Million by the end of the ... Read More

  • Cardiac Defibrillators

    ... CAGR of 7.9% over the analysis period 2024-2030. Implantable / Internal Cardiac Defibrillator, one of the segments analyzed in the report, is expected to record a 6.0% CAGR and reach US$12.3 Billion by the end ... Read More

  • Intravenous Equipment

    ... CAGR of 3.4% over the analysis period 2024-2030. IV Catheters, one of the segments analyzed in the report, is expected to record a 3.9% CAGR and reach US$4.8 Billion by the end of the analysis ... Read More

  • Laboratory Filtration Equipment

    ... at a CAGR of 8.2% over the analysis period 2024-2030. Microfiltration, one of the segments analyzed in the report, is expected to record a 8.1% CAGR and reach US$922.9 Million by the end of the ... Read More

  • Microscopes

    ... 5.0% over the analysis period 2024-2030. Optical, one of the segments analyzed in the report, is expected to record a 5.0% CAGR and reach US$3.9 Billion by the end of the analysis period. Growth in ... Read More

  • Breast Biopsy Devices

    ... at a CAGR of 5.6% over the analysis period 2024-2030. Biopsy Guidance Systems, one of the segments analyzed in the report, is expected to record a 6.0% CAGR and reach US$983.4 Million by the end ... Read More

  • ENT and Bronchoscopy Devices

    ... 2030, growing at a CAGR of 8.0% over the analysis period 2024-2030. Endoscopes, one of the segments analyzed in the report, is expected to record a 7.4% CAGR and reach US$7.8 Billion by the end ... Read More

  • Medical Displays

    ... CAGR of 5.3% over the analysis period 2024-2030. LED-Backlit LCD, one of the segments analyzed in the report, is expected to record a 5.2% CAGR and reach US$1.4 Billion by the end of the analysis ... Read More

  • Atherectomy Devices

    ... CAGR of 9.4% over the analysis period 2024-2030. Support Devices, one of the segments analyzed in the report, is expected to record a 7.3% CAGR and reach US$142.9 Million by the end of the analysis ... Read More

  • Blood Culture Tests

    ... at a CAGR of 5.9% over the analysis period 2024-2030. Conventional Blood Culture Tests, one of the segments analyzed in the report, is expected to record a 5.6% CAGR and reach US$4.3 Billion by the ... Read More

  • Cardiovascular Information Systems

    ... at a CAGR of 6.0% over the analysis period 2024-2030. Web-based Systems, one of the segments analyzed in the report, is expected to record a 5.8% CAGR and reach US$1.4 Billion by the end of ... Read More

  • Medical Waste Management

    ... at a CAGR of 4.2% over the analysis period 2024-2030. Collection, Transportation & Storage Services, one of the segments analyzed in the report, is expected to record a 4.5% CAGR and reach US$10.4 Billion by ... Read More

  • Biopsy Devices

    ... CAGR of 4.5% over the analysis period 2024-2030. Ultrasound-Guided Biopsy Devices, one of the segments analyzed in the report, is expected to record a 5.4% CAGR and reach US$2.4 Billion by the end of the ... Read More

  • Drug-Eluting Stents

    ... CAGR of 5.8% over the analysis period 2024-2030. Polymer-Free, one of the segments analyzed in the report, is expected to record a 6.0% CAGR and reach US$7.9 Billion by the end of the analysis period. ... Read More

  • Gynecological Surgical Devices

    ... at a CAGR of 2.8% over the analysis period 2024-2030. Female Sterilization & Contraceptive Devices, one of the segments analyzed in the report, is expected to record a 3.3% CAGR and reach US$9.3 Billion by ... Read More

  • Artificial Organs

    ... CAGR of 7.4% over the analysis period 2024-2030. Artificial Kidneys, one of the segments analyzed in the report, is expected to record a 8.0% CAGR and reach US$23.1 Billion by the end of the analysis ... Read More

  • Computer Assisted Surgical (CAS) Systems

    ... Billion by 2030, growing at a CAGR of 9.5% over the analysis period 2024-2030. Surgical Robots, one of the segments analyzed in the report, is expected to record a 8.4% CAGR and reach US$10.3 Billion ... Read More

  • EMS Products

    ... CAGR of 5.2% over the analysis period 2024-2030. Life Support & Emergency Resuscitation Systems, one of the segments analyzed in the report, is expected to record a 6.5% CAGR and reach US$14.6 Billion by the ... Read More

  • Coronary Stents

    ... CAGR of 5.4% over the analysis period 2024-2030. Drug Eluting Stents, one of the segments analyzed in the report, is expected to record a 5.6% CAGR and reach US$9.6 Billion by the end of the ... Read More

  • Medical Adhesives and Sealants

    ... 2030, growing at a CAGR of 7.8% over the analysis period 2024-2030. Acrylic, one of the segments analyzed in the report, is expected to record a 6.5% CAGR and reach US$4.5 Billion by the end ... Read More

  • Anatomical Models

    ... CAGR of 2.5% over the analysis period 2024-2030. The U.S. Market is Estimated at US$14.6 Billion While China is Forecast to Grow at 3.5% CAGR The Anatomical Models market in the U.S. is estimated at ... Read More

  • Medical Gloves

    ... CAGR of 7.7% over the analysis period 2024-2030. Examination Gloves Application, one of the segments analyzed in the report, is expected to record a 8.3% CAGR and reach US$11.2 Billion by the end of the ... Read More

  • Mannequin-Based Simulation

    ... CAGR of 15.2% over the analysis period 2024-2030. Patient Simulators, one of the segments analyzed in the report, is expected to record a 14.8% CAGR and reach US$4.1 Billion by the end of the analysis ... Read More

Cookie Settings